內科學科

研究成果

每年研究成果 1987 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

• 2424 Article
• 133 Review article
• 120 Letter
• 44 Comment/debate
• 90 更多
  • 35 Conference contribution
  • 34 Patent
  • 10 Editorial
  • 5 Short survey
  • 4 Conference article
  • 2 Chapter

每年研究成果

每年研究成果

搜尋結果

• 2024

  Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines (Hepatology International, (2021), 15, 6, (1421-1430), 10.1007/s12072-021-10263-x)

  Teng, W., Chang, TT., Yang, HI., Peng, CY., Su, CW., Su, TH., Hu, TH., Yu, ML., Yang, HC. & Wu, JC., 2024 6月, 於: Hepatology International. 18, 3, p. 1066 1 p.

  研究成果: Comment/debate › 同行評審

  開啟存取

  • mordant yellow 3 96%
  • Antiviral Agents 76%
  • Guidelines 57%
  • Technology 29%
  • Education 28%

• Corrigendum to “Comparison of antibiotic-resistant Escherichia coli and extra-intestinal pathogenic E. coli from main river basins under different levels of the sewer system development” [Ecotoxicol. Environ. Saf., 2023, 263, 115372] (Ecotoxicology and Environmental Safety (2023) 263, (S014765132300876X), (10.1016/j.ecoenv.2023.115372))

  Chen, J. S., Hsu, B. M., Ko, W. C. & Wang, J. L., 2024 4月 1, 於: Ecotoxicology and Environmental Safety. 274, 116188.

  研究成果: Comment/debate › 同行評審

  開啟存取

  • Ecotoxicology 100%
  • Sewer 83%
  • Antibiotics 76%
  • environmental safety 75%
  • Fosfomycin 73%

• Heart Failure with Preserved Ejection Fraction: It’s Time to Act

  Li, Y. H., 2024 3月, 於: Acta Cardiologica Sinica. 40, 2, p. 147 1 p.

  研究成果: Comment/debate › 同行評審
• 2023

  Changes in place of death trends among Asian American older adults with dementia in the United States from 2004 to 2021

  Lo, Y. T., Chi, Y. C., Chang, C. M., Kawachi, I. & Lu, T. H., 2023 11月, 於: Journal of the American Geriatrics Society. 71, 11, p. 3628-3631 4 p.

  研究成果: Comment/debate › 同行評審

• Haemoperitoneum in peritoneal dialysis and polycystic kidney disease: An interesting cause

  Wu, Z. Z., Yu, C. H. & Sung, J. M., 2023, (Accepted/In press) 於: Peritoneal Dialysis International. 43, 4, p. 342-344 3 p.

  研究成果: Comment/debate › 同行評審
• 2022

  Correction to: Predictive modeling for 14-day unplanned hospital readmission risk by using machine learning algorithms (BMC Medical Informatics and Decision Making, (2021), 21, 1, (288), 10.1186/s12911-021-01639-y)

  Lo, Y. T., Liao, J. C., Chen, M. H., Chang, C. M. & Li, C. T., 2022 12月, 於: BMC Medical Informatics and Decision Making. 22, 1, 73.

  研究成果: Comment/debate › 同行評審

  開啟存取

  • Medical informatics 100%
  • Medical Informatics 91%
  • Organized Financing 85%
  • Machine Learning 81%
  • mordant yellow 3 78%

• Corrigendum to The occurrence of and risk factors for developing acute critical illness during quarantine as a response to the COVID-19 pandemic [Journal of the Formosan Medical Association, Volume 121 (January 2022) Pages 81-88) (Journal of the Formosan Medical Association (2022) 121(1P1) (81–88)(S0929664621000358)(10.1016/j.jfma.2021.01.013))(S0929664621000358)(10.1016/j.jfma.2021.01.01)

  Tsai, C. S., Huang, T. H., Su, P. L., Chen, C. Z., Chen, C. W., Ko, W. C. & Lee, N. Y., 2022 5月, 於: Journal of the Formosan Medical Association. 121, 5, p. 1017 1 p.

  研究成果: Comment/debate › 同行評審

  開啟存取

  • Quarantine 100%
  • Pandemics 72%
  • Research Ethics Committees 71%
  • Critical Illness 63%
  • Emotions 53%

• Corrigendum to “Effects of helping relationships on health-promoting lifestyles among patients with chronic kidney disease: A randomized controlled trial” [International Journal of Nursing Studies, 126 (2022), 104137](S0020748921002820)(10.1016/j.ijnurstu.2021.104137)

  Chao, S. M., Yen, M., Lin, H. S., Sung, J. M., Hung, S. Y. & Natashia, D., 2022 9月, 於: International Journal of Nursing Studies. 133, 104280.

  研究成果: Comment/debate › 同行評審

  • Chronic Renal Insufficiency 100%
  • Nursing 90%
  • Life Style 88%
  • Emotions 86%
  • Randomized Controlled Trials 73%

• Corrigendum to “Multiplex antibacterial processes and risk in resistant phenotype by high oxidation-state nanoparticles: New killing process and mechanism investigations” [Chem. Eng. J. 409 (2021) 128266] (Chemical Engineering Journal (2021) 409, (S1385894720343783), (10.1016/j.cej.2020.128266))

  Hsu, I. L., Yeh, F. H., Chin, Y. C., Cheung, C. I., Chia, Z. C., Yang, L. X., Chen, Y. J., Cheng, T. Y., Wu, S. P., Tsai, P. J., Lee, N. Y., Liao, M. Y. & Huang, C. C., 2022 1月 15, 於: Chemical Engineering Journal. 428, 131957.

  研究成果: Comment/debate › 同行評審

  • chemical engineering 100%
  • Chemical Engineering 99%
  • Chemical engineering 97%
  • phenotype 90%
  • Nanoparticles 81%

• Low dose intra-arterial vasopressin infusion as rescue treatment for small bowel bleeding with severe thrombocytopenia

  Chou, K. Y., Chen, W. Y., Cheng, H. C. & Cheng, C. L., 2022 12月 2, 於: British Journal of Hospital Medicine. 83, 12

  研究成果: Comment/debate › 同行評審
• 2021

  A Man With Two Gastric Bulbs

  Chiang, H. C., Kang, J. W. & Lin, X. Z., 2021 9月, 於: Gastroenterology. 161, 3, p. e12-e13

  研究成果: Comment/debate › 同行評審

• Corrigendum: The Role of Toll-Like Receptor-2 in Clostridioides difficile Infection: Evidence From a Mouse Model and Clinical Patients (Front. Immunol., (2021), 12, (691039), 10.3389/fimmu.2021.691039)

  Lai, Y. H., Tsai, B. Y., Hsu, C. Y., Chen, Y. H., Chou, P. H., Chen, Y. L., Liu, H. C., Ko, W. C., Tsai, P. J. & Hung, Y. P., 2021 12月 8, 於: Frontiers in Immunology. 12, 803805.

  研究成果: Comment/debate › 同行評審

  開啟存取

  • Toll-Like Receptor 2 100%
  • Medicine 57%
  • Infections 37%
  2 引文 斯高帕斯（Scopus）

• Corrigendum to “Microfluidic colorimetric detection platform with sliding hybrid PMMA/paper microchip for human urine and blood sample analysis” [Talanta 231 (2021) 122362] (Talanta (2021) 231, (S0039914021002836), (10.1016/j.talanta.2021.122362))

  Laurenciano, C. J. D., Tseng, C. C., Chen, S. J., Lu, S. Y., Tayo, L. L. & Fu, L. M., 2021 11月 1, 於: Talanta. 234, 122693.

  研究成果: Comment/debate › 同行評審

  • Chemical Engineering 100%
  1 引文 斯高帕斯（Scopus）

• Progressive Dry Cough in a Patient with ROS1-Rearranged Lung Adenocarcinoma Undergoing Crizotinib Therapy

  Chu, C. Y., Er, H. P. & Lin, C. C., 2021 1月, 於: JAMA Oncology. 7, 1, p. 124-125 2 p., e205671.

  研究成果: Comment/debate › 同行評審
• 2020

  Blurred vision and diplopia caused by sarcoidosis orbital involvement

  Wang, C. R., Chen, Y. C., Peng, S. L. & Hsu, S. M., 2020 12月, 於: Journal of Clinical Rheumatology. 26, 8, p. e298-e299

  研究成果: Comment/debate › 同行評審
  1 引文 斯高帕斯（Scopus）
• 2019

  Corrigendum: The ATP-P2X₇ signaling axis is an essential sentinel for intracellular Clostridium difficile pathogen-induced inflammasome activation (Front. Cell. Infect. Microbiol., (2018) 8, 10.3389/fcimb.2018.00084)

  Liu, Y. H., Chang, Y. C., Chen, L. K., Su, P. A., Ko, W. C., Tsai, Y. S., Chen, Y. H., Lai, H. C., Wu, C. Y., Hung, Y. P. & Tsai, P. J., 2019, 於: Frontiers in Cellular and Infection Microbiology. 9, JUL, 260.

  研究成果: Comment/debate › 同行評審

  開啟存取

  • Inflammasomes 100%
  • Clostridium difficile 99%
  • Adenosine Triphosphate 64%
  • Medicine 60%
  2 引文 斯高帕斯（Scopus）

• Erratum: L-cube polynomial for the recognition of normal and hypertensive string-like pulse mappings in Chinese medicine (Informatics in Medicine Unlocked (2019) 16, (S235291481930276X), (10.1016/j.imu.2019.100246))

  Luo, C. H., Ye, J. W., Lin, C. Y., Lee, T. L., Tsai, L. M. & Shieh, M. D., 2019, 於: Informatics in Medicine Unlocked. 16, 100232.

  研究成果: Comment/debate › 同行評審

  開啟存取

  • Informatics 100%
  • Pulse 89%
  • Medicine 57%
  • Emotions 24%
  • Mathematics 20%

• Idiopathic Sclerosing Orbital Inflammation in a Relapsing Polychondritis Patient with Impaired Vision

  Wang, C. R., Hsu, S. M., Chen, Y. C., Ho, C. L. & Fang, S. Y., 2019 9月 1, 於: Journal of Clinical Rheumatology. 25, 6, p. E82-E83

  研究成果: Comment/debate › 同行評審

  • Relapsing Polychondritis 100%
  • Ocular Vision 54%
  • Eye Manifestations 42%
  • Exophthalmos 40%
  • Inflammation 38%
  4 引文 斯高帕斯（Scopus）
• 2018

  Corrigendum to “Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)” [J Microbiol Immunol Infect 49 (2016) 969–976] (S1684118215000213) (10.1016/j.jmii.2014.12.008))

  Jean, S. S., Lee, W. S., Yu, K. W., Liao, C. H., Hsu, C. W., Chang, F. Y., Ko, W. C., Chen, R. J., Wu, J. J., Chen, Y. H., Chen, Y. S., Liu, J. W., Lu, M. C., Lam, C., Liu, C. Y. & Hsueh, P. R., 2018 6月, 於: Journal of Microbiology, Immunology and Infection. 51, 3, p. 423-424 2 p.

  研究成果: Comment/debate › 同行評審

  開啟存取

  • ceftobiprole 100%
  • Colistin 73%
  • Carbapenems 66%
  • Intensive Care Units 47%
  • Emergency Medicine 44%
  4 引文 斯高帕斯（Scopus）

• Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)

  The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients, 2018 8月, 於: Journal of the Formosan Medical Association. 117, 8, p. 749-750 2 p.

  研究成果: Comment/debate › 同行評審

  開啟存取

  • evolocumab 84%
  • Lipids 66%
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors 65%
  • Guidelines 65%
  • alirocumab 56%
  1 引文 斯高帕斯（Scopus）

• Idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobinemia mimicking plasma cell myeloma

  Yen, C. C. & Chen, T. Y., 2018 12月 20, 於: Blood. 132, 25, p. 2700 1 p.

  研究成果: Comment/debate › 同行評審

  開啟存取
  1 引文 斯高帕斯（Scopus）

• Isolated cervical cord involvement in primary central nervous system vasculitis

  Wang, C. R., Peng, S. L. & Huang, H. W., 2018 7月 1, 於: Journal of Rheumatology. 45, 7, p. 962-963 2 p.

  研究成果: Comment/debate › 同行評審

  開啟存取
  3 引文 斯高帕斯（Scopus）

• Relapsing polychondritis as a presenting feature of acute myeloid leukaemia

  Hsu, Y. T. & Chen, T. Y., 2018 2月, 於: British Journal of Haematology. 180, 4, p. 472 1 p.

  研究成果: Comment/debate › 同行評審

  開啟存取
  3 引文 斯高帕斯（Scopus）
• 2017

  Corrigendum to “Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009” [Diagn Microbiol Infect Dis 2015;81(4):290–295] (S0732889314004076)(10.1016/j.diagmicrobio.2014.09.027)

  Jean, S. S., Lee, W. S., Bai, K. J., Yu, K. W., Hsu, C. W., Liao, C. H., Chang, F. Y., Ko, W. C., Wu, J. J., Chen, Y. H., Chen, Y. S., Liu, J. W., Lu, M. C., Liu, C. Y., Chen, R. J. & Hsueh, P. R., 2017 3月 1, 於: Diagnostic Microbiology and Infectious Disease. 87, 3, p. 298 1 p.

  研究成果: Comment/debate › 同行評審

  • Enterobacter cloacae 100%
  • Carbapenems 87%
  • Intensive Care Units 62%
  • Escherichia coli 52%
  • Medicine 36%

• Corrigendum to “The role of hepassocin in the development of non-alcoholic fatty liver disease” (Journal of Hepatology (2013) 59(5) (1065–1072) (S0168827813004145) (10.1016/j.jhep.2013.06.004))

  Wu, H. T., Lu, F. H., Ou, H. Y., Su, Y. C., Hung, H. C., Wu, J. S., Yang, Y. C., Wu, C. L. & Chang, C-J., 2017 2月 1, 於: Journal of Hepatology. 66, 2, p. 468 1 p.

  研究成果: Comment/debate › 同行評審

  • Manuscripts 100%
  • Non-alcoholic Fatty Liver Disease 92%
  • Serum 39%

• Empty marrow following previous irradiation in a patient with therapy-related myelodysplastic syndrome

  Lee, C. H. & Chen, T. Y., 2017 12月, 於: British Journal of Haematology. 179, 5, p. 703 1 p.

  研究成果: Comment/debate › 同行評審

  開啟存取

• Erratum: Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer (Oncogene (2016) 35 18 (2357-2369))

  Jen, J., Lin, L. L., Lo, F. Y., Chen, H. T., Liao, S. Y., Tang, Y. A., Su, W. C., Salgia, R., Hsu, C. L., Huang, H. C., Juan, H. F. & Wang, Y. C., 2017 8月 1, 於: Oncogene. 36, 31, 1 p.

  研究成果: Comment/debate › 同行評審

  開啟存取

  • adducin 100%
  • Oncogene Proteins 68%
  • Cyclin D1 66%
  • Oncogenes 58%
  • Lung Neoplasms 48%

• Erratum to: A novel tubulin polymerization inhibitor, MPT0B206, downregulates Bcr-Abl expression and induces apoptosis in imatinib-sensitive and imatinib-resistant CML cells (Apoptosis, (2016), 21, 9, (1008-1018), 10.1007/s10495-016-1264-z)

  Chen, C. W., Lee, Y. L., Liou, J. P., Liu, Y. H., Liu, C. W., Chen, T. Y. & Huan, H. M., 2017 10月 1, 於: Apoptosis. 22, 10, p. 1319 1 p.

  研究成果: Comment/debate › 同行評審

  • N-(1-4-methoxy-benzenesulfonyl)-2,3-dihydro-1H-indol-7-yl)formamide 100%
  • Tubulin Modulators 63%
  • Down-Regulation 27%
  • Polymerization Reaction 23%

• Unusual disc dislodgement of a björk-shiley valve after long-term implantation

  Lin, P. Y., Tsai, W. C. & Chen, J. Y., 2017 11月, 於: Korean Circulation Journal. 47, 6, p. 981 1 p.

  研究成果: Comment/debate › 同行評審
• 2015

  Diabetic ketoacidosis and related events in the canaglif lozin type 2 diabetes clinical program. Diabetes care 2015;38:1680-1686

  Ou, H. Y., Karnchanasorn, R., Chuang, L. M. & Chiu, K. C., 2015 11月, 於: Diabetes Care. 38, 11, p. e198

  研究成果: Comment/debate › 同行評審

  開啟存取
  2 引文 斯高帕斯（Scopus）

• Erratum: Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA (Gastroenterology (2014) 146 (1240-1248))

  Chan, H. L. Y., Chan, C. K., Hui, A. J., Chan, S., Poordad, F., Chang, T. T., Mathurin, P., Flaherty, J. F., Lin, L., Corsa, A., Gaggar, A., Subramanian, G. M., McHutchison, J. G., Lau, G., Lee, S. & Gane, E. J., 2015 1月 1, 於: Gastroenterology. 148, 1, p. 263 1 p.

  研究成果: Comment/debate › 同行評審
• 2014

  0434. Simulation of late inspiratory rise in airway pressure during pressure support ventilation

  Yu, C. H., Su, P. L., Lin, W. C. & Chen, C. W., 2014, 於: Intensive Care Medicine Experimental. 2, P26.

  研究成果: Comment/debate › 同行評審

  開啟存取

• Multiple mini-interviews combined with group interviews in medical student selection

  Liao, S. C., Hsiue, T. R., Lin, C. H. & Huang, A. M., 2014 11月 1, 於: Medical Education. 48, 11, p. 1104 1 p.

  研究成果: Comment/debate › 同行評審
  1 引文 斯高帕斯（Scopus）

• Uveal melanoma with diffuse bone marrow involvement

  Hsiao, S. Y. & Chen, T. Y., 2014, 於: Blood. 124, 12, p. 1996 1 p.

  研究成果: Comment/debate › 同行評審

  開啟存取
  2 引文 斯高帕斯（Scopus）
• 2012

  Bilateral pulmonary cavities in a young female

  Yang, S. C., Chen, T. Y. & Chen, W., 2012 5月, 於: QJM. 105, 5, p. 477-478 2 p., hcr021.

  研究成果: Comment/debate › 同行評審
  1 引文 斯高帕斯（Scopus）

• Erratum to "Role of moxifloxacin for the treatment of commmunity-acquired complicated intra-abdominal infections in Taiwan"

  Lau, Y. J., Chen, Y. H., Huang, C. T., Lee, W. S., Liu, C. Y., Liu, J. W., Liu, H. D., Lee, Y. J., Chen, C. W., Ko, W. C. & Hsueh, P. R., 2012 8月, 於: Journal of Microbiology, Immunology and Infection. 45, 4, p. 328 1 p.

  研究成果: Comment/debate › 同行評審

  開啟存取
• 2010

  A continuous challenge from Gram-negative bacteria: more carbapenemases.

  Chen, P. L. & Ko, W. C., 2010 10月, 於: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi. 43, 5, p. 351-353 3 p.

  研究成果: Comment/debate › 同行評審

  開啟存取
  3 引文 斯高帕斯（Scopus）
• 2009

  Minute perforation after argon plasma coagulation for management of small colonic polyps

  Chuang, C. H., Chou, T. C. & Chen, C. Y., 2009, 於: Endoscopy. 41, SUPPL. 2, p. E251-E252

  研究成果: Comment/debate › 同行評審
  4 引文 斯高帕斯（Scopus）
• 2008

  Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients (Journal of Viral Hepatitis 13, 336-342))

  Huang, Y. H., Wu, J. C., Chang, T. T., Sheen, I. J., Huo, T. I., Lee, P. C., Su, C. W. & Lee, S. D., 2008 2月, 於: Journal of Viral Hepatitis. 15, 2, p. 156 1 p.

  研究成果: Comment/debate › 同行評審

  開啟存取
• 2007

  Erratum: Anti-Lewis X antibody promotes Helicobacter pylori adhesion to gastric epithelial cells (Infection and Immunity (2007) 75, 6, (2661-2667))

  Sheu, S. M., Sheu, B. S., Yang, H. B., Lei, H. Y. & Wu, J. J., 2007 8月, 於: Infection and Immunity. 75, 8, p. 4188 1 p.

  研究成果: Comment/debate › 同行評審
  1 引文 斯高帕斯（Scopus）
• 2006

  Corrigendum to "Klebsiella pneumoniae fascial space infections of the head and neck in Taiwan: emphasis on diabetic patients and repetitive infections" [Journal of Infection 2005;50(1):34-40] (DOI:10.1016/j.jinf.2003.11.014)

  Chang, C. M., Lu, F. H., Guo, H. R. & Ko, W. C., 2006 9月, 於: Journal of Infection. 53, 3, p. 215 1 p.

  研究成果: Comment/debate › 同行評審

  開啟存取
• 2005

  Erratum: Host gastric Lewis expression determines the bacterial density of Helicobacter pylori in babA2 genopositive infection (Gut (July 2003) 52 (927-932))

  Sheu, B. S., Sheu, S. M., Yang, H. B., Huang, A. H. & Wu, J. J., 2005 3月, 於: Gut. 54, 3, p. 442 1 p.

  研究成果: Comment/debate › 同行評審
• 2004

  H. pylori eradication does not reduce gastric cancer incidence in a high-risk area of China

  Sheu, B. S. & Lin, X. Z., 2004 8月, 於: Evidence-Based Healthcare. 8, 4, p. 218-220 3 p.

  研究成果: Comment/debate › 同行評審

  • Pylorus 100%
  • Stomach Neoplasms 76%
  • Placebos 50%
  • Incidence 42%
  • Smoking 10%
  1 引文 斯高帕斯（Scopus）
• 1995

  Combining endoscopy with DICIDA scanning to evaluate prolonged epigastralgia after choledochoduodenostomy

  Sheu, B. S., Lin, P. W., Lin, X. Z. & Lin, C. Y., 1995, 於: Endoscopy. 27, 9, p. 708-709 2 p.

  研究成果: Comment/debate › 同行評審

  開啟存取